Top Midday Decliners

MT Newswires Live08-18

EyePoint (EYPT) said its phase 3 Lugano trial testing Duravyu in patients with wet age-related macular degeneration failed to achieve its primary endpoint. JPMorgan downgraded EyePoint to neutral from overweight.

Shares slumped 69% as intraday trading volume catapulted to almost 40.4 million from a daily average of about 1.48 million.

Enovix (ENVX) Chief Executive Officer and director Raj Talluri resigned on Aug. 13 to pursue another opportunity, the company said Monday. The company named Chief Financial Officer Ryan Benton interim CEO while conducting an internal and external search for a permanent CEO.

Shares plunged 18% as intraday trading volume catapulted to over 24.4 million from a daily average of more than 6.45 million.

Corvex (MOVE) reported a wider Q2 loss amid a surge in year-over-year sales late Friday.

Shares declined 10%, with intraday trading volume at over 66,000, versus a daily average of about 183,000.

Price: 4.53, Change: -10.23, Percent Change: -69.32

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2660310994?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 02:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2660310994","market":"sg","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/EYPT\">EyePoint</a> (EYPT) said its phase 3 Lugano trial testing Duravyu in patients with wet age-related macular degeneration failed to achieve its primary endpoint. JPMorgan downgraded EyePoint to neutral from overweight.</p><p>Shares slumped 69% as intraday trading volume catapulted to almost 40.4 million from a daily average of about 1.48 million.</p><p>Enovix (ENVX) Chief Executive Officer and director Raj Talluri resigned on Aug. 13 to pursue another opportunity, the company said Monday. The company named Chief Financial Officer Ryan Benton interim CEO while conducting an internal and external search for a permanent CEO.</p><p>Shares plunged 18% as intraday trading volume catapulted to over 24.4 million from a daily average of more than 6.45 million.</p><p>Corvex (MOVE) reported a wider Q2 loss amid a surge in year-over-year sales late Friday.</p><p>Shares declined 10%, with intraday trading volume at over 66,000, versus a daily average of about 183,000.</p><p>Price: 4.53, Change: -10.23, Percent Change: -69.32</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-18 02:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/EYPT\">EyePoint</a> (EYPT) said its phase 3 Lugano trial testing Duravyu in patients with wet age-related macular degeneration failed to achieve its primary endpoint. JPMorgan downgraded EyePoint to neutral from overweight.</p><p>Shares slumped 69% as intraday trading volume catapulted to almost 40.4 million from a daily average of about 1.48 million.</p><p>Enovix (ENVX) Chief Executive Officer and director Raj Talluri resigned on Aug. 13 to pursue another opportunity, the company said Monday. The company named Chief Financial Officer Ryan Benton interim CEO while conducting an internal and external search for a permanent CEO.</p><p>Shares plunged 18% as intraday trading volume catapulted to over 24.4 million from a daily average of more than 6.45 million.</p><p>Corvex (MOVE) reported a wider Q2 loss amid a surge in year-over-year sales late Friday.</p><p>Shares declined 10%, with intraday trading volume at over 66,000, versus a daily average of about 183,000.</p><p>Price: 4.53, Change: -10.23, Percent Change: -69.32</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EYPT","symbol_name":"EyePoint","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2660310994","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2660310994","pubTimestamp":1786990924,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EyePoint  said its phase 3 Lugano trial testing Duravyu in patients with wet age-related macular degeneration failed to achieve its primary endpoint. JPMorgan downgraded EyePoint to neutral from overweight.Shares slumped 69% as intraday trading volume catapulted to almost 40.4 million from a daily average of about 1.48 million.Enovix  Chief Executive Officer and director Raj Talluri resigned on Aug. 13 to pursue another opportunity, the company said Monday. The company named Chief Financial Officer Ryan Benton interim CEO while conducting an internal and external search for a permanent CEO.Shares plunged 18% as intraday trading volume catapulted to over 24.4 million from a daily average of more than 6.45 million.Corvex  reported a wider Q2 loss amid a surge in year-over-year sales late Friday.Shares declined 10%, with intraday trading volume at over 66,000, versus a daily average of about 183,000.Price: 4.53, Change: -10.23, Percent Change: -69.32","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EYPT":"EyePoint","BK4588":"碎股","ENVX":"Enovix Corporation","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4585":"ETF&股票定投概念","BK4170":"电脑硬件、储存设备及电脑周边","MOVE":"Corvex Inc","BK4096":"电气部件与设备","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4007":"制药"},"translate_title":"午盘跌幅最大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MOVE":1,"ENVX":1,"EYPT":1},"content_text":"EyePoint (EYPT) said its phase 3 Lugano trial testing Duravyu in patients with wet age-related macular degeneration failed to achieve its primary endpoint. JPMorgan downgraded EyePoint to neutral from overweight.Shares slumped 69% as intraday trading volume catapulted to almost 40.4 million from a daily average of about 1.48 million.Enovix (ENVX) Chief Executive Officer and director Raj Talluri resigned on Aug. 13 to pursue another opportunity, the company said Monday. The company named Chief Financial Officer Ryan Benton interim CEO while conducting an internal and external search for a permanent CEO.Shares plunged 18% as intraday trading volume catapulted to over 24.4 million from a daily average of more than 6.45 million.Corvex (MOVE) reported a wider Q2 loss amid a surge in year-over-year sales late Friday.Shares declined 10%, with intraday trading volume at over 66,000, versus a daily average of about 183,000.Price: 4.53, Change: -10.23, Percent Change: -69.32","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2660310994","isCrawlerRequest":true}